CBD Unlimited provides high quality CBD hemp oil and cannabidiol products for our customers, derived from pure hemp. Our products are scientifically formulated for controlled dosing and targeted delivery, ensuring customers receive the best regulated potential benefits cannabidiol has to offer.
Studies have shown CBD to have a broad range of potential medicinal benefits, and we’re proud to provide only the best cannabidiol products to our customers. We have a broad range of high quality hemp based products, ranging from pure CBD hemp oil and CBD isolate, to CBD sleep aid and cannabidiol infused chai tea.
All of our CBD products are extracted from high quality hemp sourced from within the USA. Tested thoroughly by third party laboratories and certified 100% pure by the State of Arizona, our cannabidiol products contain between 1.8-2.5% concentration of cannabidiol in each product.
CBD Unlimited provides CBD solutions for the entire family, including our furry family members. Discover our Phyto-Bites CBD dog treats for large and small dogs as well as cats, 2-5mg of concentrated CBD is packed into each and every bite.
Become your own best advocate for health by ordering from CBD Unlimited today. A growing number of scientific studies have shown CBD to have a broad range of potential medicinal benefits, and with 0.3% or less THC, none of our products will get you high. Learn more and order your CBD hemp oil today by reaching out to our staff.
About CBD Unlimited, Inc.
CBD Unlimited, Inc. develops and distributes all-natural CBD products derived from cannabis sativa plant (Hemp), containing less than 0.3% THC. Its products range from oils, capsules, topicals, and pet products, all with the shared purpose of therapeutic and pain relief for humans and pets. Phyto-Bites are CBD soft chews for animal use that are formulated to promote health and support the reduction of separation anxiety, pain, and inflammation. The science behind these products involves over a half a decade of research and experiments in order to protect the accuracy in dosage and delivery of absorption per each serving.
In the interest of providing conformity with federal and state mandates, the company has incorporated the “Gorilla-Tek” platform into its business practices. The Gorilla-Tek platform is the first standardized hardware agnostic and software solution that tracks high-risk, high-shrink regulated, and restricted products maintained under federal/state/local compliance. The platform provides asset protection, inventory management, compliance and an “end of sale” technology integration. Based on principles developed by the pharmacological industry, the integrated “Gorilla-Tek” platform is tremendously efficient as it provides up-to-the-minute accounting and product details. Gorilla-Tek increases productivity, while reducing costs for retailers and costs in time for customers.
Safe Harbor Notice
This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The company undertakes no obligation to update any forward-looking statements.
For further investor and media information, contact:
CBD Unlimited, Inc.
Chairman & CEO